population health

Conference Coverage

12/06/2016

JCP Editors

Founded in 1958, the American Society of Hematology (ASH) is considered the premier professional society for physicians and scientists specializing in benign and malignant blood disorders. The organization is...

...

12/06/2016

Journal of Clinical Pathways

Research in Review

Blood Test Helps Predict Treatment Response for Patients With SCLC

11/29/2016

JCP Editors

Patterns of gene copy number aberrations (CNAs) in isolated small-cell lung cancer (SCLC) cells may help determine how patients will respond to chemotherapy, according to a study published...

...

11/29/2016

Journal of Clinical Pathways

Research in Review

HC-Based Next-Gen Sequencing Aids Treatment Decisions in Lung Cancer

11/23/2016

JCP Editors

Hybrid capture (HC)-based next-generation sequencing (NGS) can identify targetable oncogenic drivers to improve response rates in patients with lung cancer, according to a study published in the Journal of Thoracic...

Hybrid...

11/23/2016

Journal of Clinical Pathways

Research in Review

TKI Drug Improves Survival in Metastatic Kidney Cancer

11/22/2016

JCP Editors

First-line therapy with cabozantinib was superior to standard of care sunitinib with respect to progression-free survival and objective response rate for patients with intermediate- or poor-risk metastatic renal cell...

...

11/22/2016

Journal of Clinical Pathways

Research in Review

Combining Targeted Therapies Provides Optimal Treatment for CML

11/17/2016

JCP Editors

Using mathematical modeling, researchers have determined the best combination and sequencing of targeted therapies for the treatment of chronic myeloid leukemia (CML). Their results have been published in PLOS...

Using...

11/17/2016

Journal of Clinical Pathways

Research in Review

New Treatment Effective for B-Cell Precursor ALL in Pediatric Patients

11/17/2016

JCP Editors

Single-agent blinatumomab demonstrated antileukemia activity in pediatric patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL), according to a study published in the Journal of...

...

11/17/2016

Journal of Clinical Pathways

Interview

ACS CAN Addresses Controversy Surrounding Opioids

11/15/2016

Mark Fleury, PhD, MS

An interview with Mark Fleury, PhD, MS, principal, Policy Development, Emerging Science, American Cancer Society Cancer Action Network, Washington, DC.  Pain as a result of cancer or cancer treatment...

An...

11/15/2016

Journal of Clinical Pathways

Interview

Making Decisions About New Cancer Treatments With Limited Evidence

11/15/2016

Jim C Hu, MD, MPH

An interview with Jim C Hu, MD, MPH, urologic oncologist and director of the LeFrak Center for Robotic Surgery at NewYork-Presbyterian and Weill Cornell Medicine, New York, NY.  Prostate cancer...

An...

11/15/2016

Journal of Clinical Pathways

Research in Review

Pediatric Stroke Pathway Improves Time to Definitive Diagnosis

11/15/2016

JCP Editors

A pediatric stroke clinical pathway significantly improved time to definitive diagnosis while also streamlining the care provided to children presenting to the pediatric emergency department (ED) with focal...

A...

11/15/2016

Journal of Clinical Pathways

Research in Review

NET Equally Effective, Safer Than Neoadjuvant Chemotherapy for ER+ Breast Cancer

11/11/2016

JCP Editors

Neoadjuvant endocrine therapy may be just as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast cancer with considerably fewer adverse events, according to a...

...

11/11/2016

Journal of Clinical Pathways